Countries South Korea

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...

 November 28, 2022 | News

Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea

-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...

 November 28, 2022 | News

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) of Australia for the indication of gl...

 November 25, 2022 | News

Lunit Partners with CARPL.ai to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels

Lunit signed a global distribution agreement to provide its AI-based radiology solutions for clinical use via CARPL.ai's platform The partnership will d...

 November 24, 2022 | News

제조 실행 소프트웨어(MES) 도입에 대한 6가지 일반적인 오해 해소

    제조 실행 소프트웨어(MES) 도입에 대한 6가지 ...

 November 22, 2022 | News

Lunit Becomes the First Medical Software Company in Asia-Pacific to Become MDR CE and UKCA Certified

  Lunit becomes first software as a medical device (SaMD) company in APAC to become MDR CE and UKCA certified MDR and UKCA certifications are requ...

 November 22, 2022 | News

MEDICOX Signs Contract with ORAMED to Distribute Oral Insulin in South Korea

  MEDICOX secures distribution right for ORAMED's oral insulin in South Korea after phase 3 of FDA approval- Contract scale up to 18...

 November 21, 2022 | News

Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project

Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScreen NSW's AI evaluation and clinical integration...

 November 17, 2022 | News

Standigm Synthetic Research Center successfully accelerates drug discovery in its first year

Standigm, the workflow AI-driven drug discovery company, today announced the celebration of its Synthetic Research Center's first year. In the last 12 mont...

 November 17, 2022 | News

Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

HitGen will apply its DNA-encoded library (DEL) technology platform centered around the design, synthesis and screening of thousands of DELs that collectiv...

 November 14, 2022 | News

Pharma 4.0 및 현대 제조를 위한 궁극적인 가이드

                                        &nb...

 November 08, 2022 | News

Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research

Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping. Lunit's presentations this year will highl...

 November 08, 2022 | News

Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA

The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being develop...

 November 07, 2022 | News

Samyang Holdings' Lafullen Makes Splash in Korean Medical Aesthetics Market

- Successfully demonstrated Lafullen's safety and efficacy at autumn medical symposiums - Shared treatment protocols and clinical cases to lecturers by sp...

 November 01, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close